Authors:
HONKOOP AH
HOEKMAN K
VANGROENINGEN CJ
VANDERWALL E
WAGSTAFF J
PINEDO HM
Citation: Ah. Honkoop et al., DOSE-INTENSIVE NEOADJUVANT CHEMOTHERAPY WITH GM-CSF IN LOCALLY ADVANCED BREAST-CANCER (LABC) - A CHEMO-IMMUNOTHERAPEUTIC APPROACH, European journal of cancer, 34, 1998, pp. 23-23
Authors:
HONKOOP AH
VANDIEST PJ
DEJONG JS
LINN SC
GIACCONE G
HOEKMAN K
WAGSTAFF J
PINEDO HM
Citation: Ah. Honkoop et al., PROGNOSTIC ROLE OF CLINICAL, PATHOLOGICAL AND BIOLOGICAL CHARACTERISTICS IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, British Journal of Cancer, 77(4), 1998, pp. 621-626
Authors:
HONKOOP AH
VANDERWALL E
FELLER N
SCHUURHUIS GJ
VANDERVIJGH WJF
BOVEN E
VANGROENINGEN CJ
GIACCONE G
HOEKMAN K
VERMORKEN JB
WAGSTAFF J
PINEDO HM
Citation: Ah. Honkoop et al., MULTIPLE CYCLES OF HIGH-DOSE DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 8(10), 1997, pp. 957-962
Authors:
LINN SC
PINEDO HM
VANARKOTTE J
VANDERVALK P
HOEKMAN K
HONKOOP AH
VERMORKEN JB
GIACCONE G
Citation: Sc. Linn et al., EXPRESSION OF DRUG-RESISTANCE PROTEINS IN BREAST-CANCER, IN RELATION TO CHEMOTHERAPY, International journal of cancer, 71(5), 1997, pp. 787-795
Authors:
HONKOOP AH
PINEDO HM
DEJONG JS
VERHEUL HMW
LINN SC
HOEKMAN K
WAGSTAFF J
VANDIEST PJ
Citation: Ah. Honkoop et al., EFFECTS OF CHEMOTHERAPY ON PATHOLOGICAL AND BIOLOGIC CHARACTERISTICS OF LOCALLY ADVANCED BREAST-CANCER, American journal of clinical pathology, 107(2), 1997, pp. 211-218
Authors:
HONKOOP AH
HOEKMAN K
WAGSTAFF J
BOVEN E
VANGROENINGEN CJ
GIACCONE G
VERMORKEN JB
PINEDO HM
Citation: Ah. Honkoop et al., DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN, CYCLOPHOSPHAMIDE AND GM-CSF FAILS TO IMPROVE SURVIVAL OF METASTATIC BREAST-CANCER PATIENTS, Annals of oncology, 7(1), 1996, pp. 35-39
Authors:
HONKOOP AH
HOEKMAN K
WAGSTAFF J
VANGROENINGEN CJ
VERMORKEN JB
BOVEN E
PINEDO HM
Citation: Ah. Honkoop et al., CONTINUOUS-INFUSION OR SUBCUTANEOUS INJECTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - INCREASED EFFICACY AND REDUCED TOXICITYWHEN GIVEN SUBCUTANEOUSLY, British Journal of Cancer, 74(7), 1996, pp. 1132-1136
Authors:
LINN SC
HONKOOP AH
HOEKMAN K
VANDERVALK P
PINEDO HM
GIACCONE G
Citation: Sc. Linn et al., P53 AND P-GLYCOPROTEIN ARE OFTEN COEXPRESSED AND ARE ASSOCIATED WITH POOR-PROGNOSIS IN BREAST-CANCER, British Journal of Cancer, 74(1), 1996, pp. 63-68
Citation: Ah. Honkoop et Hm. Pinedo, HIGH-DOSE CHEMOTHERAPY IN THE TREATMENT OF BREAST-CANCER, International journal of oncology, 6(4), 1995, pp. 911-918